Chronic microglial activation and sustained LCN2 production contribute to the inflammatory milieu in multiple sclerosis (MS) 5, while in Alzheimer's disease (AD), microglial activation and LCN2 production are linked to neuroinflammation and neuronal damage 6. Here, LCN2 is linked to Alzheimer disease.